Cystatin-C and mortality in elderly persons with heart failure
- 13 January 2005
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (2) , 268-271
- https://doi.org/10.1016/j.jacc.2004.09.061
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Renal Function, Digoxin Therapy, and Heart Failure OutcomesJournal of the American Society of Nephrology, 2004
- Serum Cystatin C May Be a Better Marker of Renal Impairment than CreatinineJournal of the American Geriatrics Society, 2003
- Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health StudyAnnals of Internal Medicine, 2002
- Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- Serum cystatin C concentration as a marker of renal dysfunction in the elderlyAmerican Journal of Kidney Diseases, 2001
- Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II SystemScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health StudyAnnals of Epidemiology, 1995
- Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinineKidney International, 1995
- Spurious Correlation and the Fallacy of the Ratio Standard RevisitedJournal of the Royal Statistical Society Series A: Statistics in Society, 1993
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991